pSivida Announces Positive Results from the 36 Month Readout of Completed Phase 3 FAME

by Benzinga Staff
February 3, 2011 4:26 PM | 8 seconds read |
pSivida Corp. PSDV today announced month 36, top-line readout results for the FAME Study prepared by its licensee, Alimera Sciences, Inc..
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDAHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!